Eric Brandt Named as Allergan's Corporate Vice President and Chief Financial Officer.IRVINE, Calif.--(BW HealthWire)--April 27, 1999-- Allergan, Inc. (NYSE: AGN) announced today that Eric Brandt has been selected as Allergan's Corporate Vice President and Chief Financial Officer. He will assume his duties on May 24, 1999. "After a thorough search, I am delighted to have a candidate of Eric's caliber and capabilities join Allergan," commented David E. I. Pyott, President and Chief Executive Officer. "As we look to the future and the task of further building Allergan's value, Eric's unique skill set will allow him to become another key contributor to the Company's Executive team. Eric's multifaceted financial and strategic perspectives should help us expand and accelerate the steadily improving performance underway at Allergan," continued Mr. Pyott. "Eric has a national reputation as one of the best strategic financial consultants within health care. His knowledge of our global industry, experience with mergers and acquisitions, competitive practices and strategic partnering, as well as his keen grasp of the financial management of pharmaceutical companies, are skills that will clearly add value to the exceptionally strong financial competencies already present within Allergan." Mr. Brandt joins Allergan from the Boston Consulting Group where over the prior ten years he progressively rose to the position of Vice President and Partner, and a senior member of the BCG BCG - Bacillus of Calmette and Guerin (tuberculosis vaccine; trademark of Institut Pasteur, Paris, France) BCG - Bakalian Consulting Group BCG - Ballistocardiogram BCG - Baroque Choral Guild BCG - Belgisch Centrum voor Geleidehonden vzw BCG - Benefits Connection Group BCG - Bi-Conjugate Gradient BCG - Bicolor Guaiac Test BCG - Bingham Calnan Group BCG - Bioinformatics & Computational Genomics BCG - Biological Crystal Growth Health Care practice. At the Boston Consulting Group, Mr. Brandt was involved in high level consulting engagements with several of the top ten global pharmaceutical companies as well as with numerous managed care and medical device companies. The principal form of Mr. Brandt's professional practice has been advising clients in the areas of corporate finance, deal valuation, post merger integration, business economics and performance, marketing strategy, total stockholder return, and corporate development. Mr. Brandt currently leads BCG's operational effectiveness practice which focuses on supply chain management, productivity and routes to improve organizational performance. Mr. Brandt graduated with a Bachelor of Science degree in Chemical Engineering from Massachusetts Institute of Technology in 1984. He worked in a variety of manufacturing and research and development settings until returning to school and obtaining a Masters degree in Business Administration from Harvard University in 1989. Allergan, Inc., headquartered in Irvine, California, is a technology-driven, global health care company, providing eye care and specialty pharmaceutical products worldwide. Allergan develops and commercializes products in the eye care pharmaceutical, ophthalmic surgical device, over-the-counter contact lens care, movement disorder, and dermatological markets that deliver value to our customers, satisfy unmet medical needs and improve patients' lives. |
|
||||||||||||||||

Printer friendly
Cite/link
Email
Feedback
Reader Opinion